Ellevest, Inc. Syros Pharmaceuticals, Inc. Call Options Transaction History
Ellevest, Inc.
- $1.8 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
About Syros Pharmaceuticals, Inc.
- Ticker SYRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,236,200
- Market Cap $4.25M
- Description
- Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...